Cyteir Therapeutics, Inc. - 23284P103
Sector:
Healthcare
· Industry:
Pharmaceutical Preparations
Website:
No information yet
· Social:
No information yet
Company profile
Description is not available for this instrument yet.
Quarter snapshot
Latest / Compare
Q4 2023
· Q3 2023
Value (USD)
Total reported value ($000)
$10.04M
QoQ value delta ($000)
+$1.802M
(+21.89%)
Implied price effect (QoQ)
+7.08%
Shares
Total shares
3,302,868
QoQ shares delta
+401,302
(+13.83%)
Total shares held by funds (by quarter)
Top holders (Q4 2023)
Top 25 only
Full list
| Manager | Value ($000) | Shares | % of 13F |
|---|---|---|---|
| GABELLI FUNDS LLC | 3,374 | 1,110,050 | 0.03% |
| VANGUARD GROUP INC | 2,089 | 687,391 | 0.0% |
| MILLENNIUM MANAGEMENT LLC | 1,374 | 451,980 | 0.0% |
| Walleye Capital LLC | 1,298 | 427,037 | 0.0% |
| GEODE CAPITAL MANAGEMENT, LLC | 541 | 177,930 | 0.0% |
| BANK OF AMERICA CORP /DE/ | 271 | 89,304 | 0.0% |
| NORTHERN TRUST CORP | 207 | 68,283 | 0.0% |
| Squarepoint Ops LLC | 204 | 67,219 | 0.0% |
| BANK OF MONTREAL /CAN/ | 203 | 66,300 | 0.0% |
| STATE STREET CORP | 140 | 46,153 | 0.0% |
| JANE STREET GROUP, LLC | 126 | 41,602 | 0.0% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 99 | 32,800 | 0.0% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 48 | 15,972 | 0.0% |
| XTX Topco Ltd | 32 | 10,596 | 0.01% |
| ROYAL BANK OF CANADA | 16 | 5,357 | 0.0% |
| Tower Research Capital LLC (TRC) | 9 | 3,049 | 0.0% |
| MORGAN STANLEY | 3 | 1,000 | 0.0% |
| WOLVERINE ASSET MANAGEMENT LLC | 1 | 570 | 0.0% |
| JPMORGAN CHASE & CO | 0 | 124 | 0.0% |
| WELLS FARGO & COMPANY/MN | 0 | 147 | 0.0% |
| Qube Research & Technologies Ltd | 0 | 4 | 0.0% |